New insights regarding HCV-NS5A structure/function and indication of genotypic differences

<p>Abstract</p> <p>Background</p> <p>HCV is prevalent throughout the world. It is a major cause of chronic liver disease. There is no effective vaccine and the most common therapy, based on Peginterferon, has a success rate of ~50%. The mechanisms underlying viral resis...

Full description

Bibliographic Details
Main Authors: Yamasaki Lilian HT, Arcuri Helen A, Jardim Ana Carolina G, Bittar Cintia, de Carvalho-Mello Isabel Maria VG, Rahal Paula
Format: Article
Language:English
Published: BMC 2012-01-01
Series:Virology Journal
Subjects:
Online Access:http://www.virologyj.com/content/9/1/14